Assignee
AMGEN CANADA INC
CA13 patents
Top patents by PatentIndex Score
US6468528B1Oct 22, 2002
Materials and methods to inhibit Hodgkin and Reed Sternberg cell growth
AMGEN CANADA INC67 citations93
US5919656AJul 6, 1999
Genes encoding telomerase protein 1
AMGEN CANADA INC40 citations93
US5907079AMay 25, 1999
MSH2 disrupted mice develop lymphomas
AMGEN CANADA INC57 citations91
US7312024B2Dec 25, 2007
Materials and methods to inhibit Hodgkin and Reed Sternberg cell growth
AMGEN CANADA INC26 citations89
US5962636AOct 5, 1999
Peptides capable of modulating inflammatory heart disease
AMGEN CANADA INC55 citations89
US5714667AFeb 3, 1998
Mice lacking expression of CTLA-4 receptor
AMGEN CANADA INC18 citations84
US6492138B1Dec 10, 2002
Polynucleotides encoding a novel SHC-binding protein
AMGEN CANADA INC15 citations83
US6773911B1Aug 10, 2004
Apoptosis-inducing factor
AMGEN CANADA INC6 citations65
US6034230AMar 7, 2000
Nucleic acids encoding myocardial peptides
AMGEN CANADA INC10 citations65
US5891666AApr 6, 1999
Genes encoding LSIRF polypeptides
AMGEN CANADA INC3 citations58
US6369202B1Apr 9, 2002
Genes encoding LSIRF polypeptides
AMGEN CANADA INC1 citations55
US6258935B1Jul 10, 2001
LSIRF polypeptides
AMGEN CANADA INC0 citations45
US6399747B1Jun 4, 2002
Shc-binding protein
AMGEN CANADA INC0 citations43